Resources
Is Your CRO a Genuine Operational Partner?
ARG's history of successfully operationalizing rare disease clinical research has been driven by comprehensive engagement with our sponsors.
April 6, 2018
Does Your CRO Attract and Retain Talent?
In a recent engagement survey, 98.6% of employees indicated they believe ARG cares about them, and 97.8% responded that they see themselves working for ARG for many years to come.
March 20, 2018
Does Your CRO Partner With a Specialty Pharmacy?
ARG is always exploring avenues to further leverage our unique relationships to provide additional value to our sponsors. This includes a one-of-a-kind partnership with a national specialty pharmacy.
March 6, 2018
ARG rescues Phase I oncology trial using TrialVista® CTMS
Challenge: A leading specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory […]
March 1, 2018
Preferred Provider Status for Atlantic Research Group
Challenge: A specialty biopharmaceutical company targeting the therapeutic power of plasma for the treatment of chronic, life-altering diseases like hemophilia […]
February 1, 2018
Does Your CRO Automate its Validation Processes?
By using a smarter automated approach to validation, we are able to cut down build timelines as well as identify and correct more errors prior to go-live.
January 18, 2018